Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]-

Request For Quotation
Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]- Suppliers list
Company Name: ShangHai ChuanQian Chemcial Technique Centre  
Tel: 15869524721
Email: 3525679403@qq.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-1647117 13681763483
Email: product02@bidepharm.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Email: sales@chemhifuture.com
Company Name: RD International Technology Co., Limited  
Tel: 18024082417
Email: market@ubiochem.com
Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]- Basic information
Product Name:Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]-
Synonyms:Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]-;THZ-P1-2;(E)-N-(3-((6-(1H-Indol-3-yl)pyrimidin-4-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide
CAS:2058075-45-7
MF:C31H29N7O2
MW:531.61
EINECS:
Product Categories:
Mol File:2058075-45-7.mol
Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]- Structure
Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]- Chemical Properties
Boiling point 765.2±60.0 °C(Predicted)
density 1.334±0.06 g/cm3(Predicted)
pka12.94±0.70(Predicted)
form Solid
color Light yellow to yellow
Safety Information
MSDS Information
Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]- Usage And Synthesis
UsesTHZ-P1-2 is a first-in-class and selective PI5P4K inhibitor, with an IC50 of 190 nM for PI5P4Kα. THZ-P1-2 covalently targets cysteines on a disordered loop in PI5P4Kα/β/γ. THZ-P1-2 causes autophagy disruption and upregulates TFEB signaling. THZ-P1-2 displays anticancer activity in leukemia cell lines[1].
References[1] Sivakumaren SC, et al. Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors. Cell Chem Biol. 2020;27(5):525‐537.e6. DOI:10.1016/j.chembiol.2020.02.003
Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]- Preparation Products And Raw materials
Tag:Benzamide, 4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[3-[[6-(1H-indol-3-yl)-4-pyrimidinyl]amino]phenyl]-(2058075-45-7) Related Product Information
Doxorubicin hydrochloride Forskolin Olaparib Ruxolitinib Rapamycin Metformin